EC Number |
Inhibitors |
Structure |
---|
2.3.1.48 | (1E,4Z,6E)-1,7-bis(3-bromo-4-hydroxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one |
cinnamoyl-II |
|
2.3.1.48 | (1E,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxyphenyl)hepta-1,4,6-trien-3-one |
BDMC |
|
2.3.1.48 | (1E,4Z,6E)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one |
DMC |
|
2.3.1.48 | (2-ethoxypropoxy)benzene |
- |
|
2.3.1.48 | (2E)-2-(ethoxycarbonyl)heptadec-2-enoic acid |
- |
|
2.3.1.48 | (2E)-2-(ethoxycarbonyl)hexadec-2-enoic acid |
- |
|
2.3.1.48 | (2E)-2-acetylhexadec-2-enoic acid |
- |
|
2.3.1.48 | (2E)-2-acetylpentadec-2-enoic acid |
- |
|
2.3.1.48 | (2E,6E)-2,6-bis[(3,4-dihydroxyphenyl)methylidene]cyclohexan-1-one |
89% residual activity at 0.1 mM |
|
2.3.1.48 | (2E,6E)-2,6-bis[(3,5-dibromo-4-hydroxyphenyl)methylidene]cyclohexan-1-one |
complete inhibition at 0.1 mM |
|